Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck.

Göke F, Bode M, Franzen A, Kirsten R, Goltz D, Göke A, Sharma R, Boehm D, Vogel W, Wagner P, Lengerke C, Kristiansen G, Kirfel J, Van Bremen T, Bootz F, Heasley LE, Schröck A, Perner S.

Mod Pathol. 2013 Oct;26(10):1298-306. doi: 10.1038/modpathol.2013.58. Epub 2013 Apr 26.

2.

Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancer.

Schröck A, Göke F, Wagner P, Bode M, Franzen A, Huss S, Agaimy A, Ihrler S, Kirsten R, Kristiansen G, Bootz F, Lengerke C, Perner S.

Head Neck. 2014 Sep;36(9):1253-7. doi: 10.1002/hed.23443. Epub 2014 Feb 1.

PMID:
23913758
3.

Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.

Schröck A, Bode M, Göke FJ, Bareiss PM, Schairer R, Wang H, Weichert W, Franzen A, Kirsten R, van Bremen T, Queisser A, Kristiansen G, Heasley L, Bootz F, Lengerke C, Perner S.

Carcinogenesis. 2014 Jul;35(7):1636-42. doi: 10.1093/carcin/bgu094. Epub 2014 Apr 17.

PMID:
24743512
4.

Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.

Nakano T, Yamamoto H, Nakashima T, Nishijima T, Satoh M, Hatanaka Y, Shiratsuchi H, Yasumatsu R, Toh S, Komune S, Oda Y.

Hum Pathol. 2016 Apr;50:51-61. doi: 10.1016/j.humpath.2015.11.001. Epub 2015 Nov 17.

PMID:
26997438
5.

Prognostic implications of FGFR1 and MYC status in esophageal squamous cell carcinoma.

Kwon D, Yun JY, Keam B, Kim YT, Jeon YK.

World J Gastroenterol. 2016 Nov 28;22(44):9803-9812.

6.

FGFR1 amplification in squamous cell carcinoma of the lung.

Heist RS, Mino-Kenudson M, Sequist LV, Tammireddy S, Morrissey L, Christiani DC, Engelman JA, Iafrate AJ.

J Thorac Oncol. 2012 Dec;7(12):1775-80. doi: 10.1097/JTO.0b013e31826aed28.

7.

Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors.

Göke F, Franzen A, Menon R, Goltz D, Kirsten R, Boehm D, Vogel W, Göke A, Scheble V, Ellinger J, Gerigk U, Fend F, Wagner P, Schroeck A, Perner S.

Chest. 2012 Oct;142(4):1020-1026. doi: 10.1378/chest.11-2943.

PMID:
22499828
8.

Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.

Singh B, Stoffel A, Gogineni S, Poluri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, Rao PH.

Am J Pathol. 2002 Aug;161(2):365-71.

9.

FGFR1 Amplification in Squamous Cell Carcinoma of the Lung with Correlation of Primary and Metastatic Tumor Status.

Monaco SE, Rodriguez EF, Mahaffey AL, Dacic S.

Am J Clin Pathol. 2016 Jan;145(1):55-61. doi: 10.1093/ajcp/aqv013.

PMID:
26712871
10.

Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis.

Meredith SD, Levine PA, Burns JA, Gaffey MJ, Boyd JC, Weiss LM, Erickson NL, Williams ME.

Arch Otolaryngol Head Neck Surg. 1995 Jul;121(7):790-4.

PMID:
7598859
11.

Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma.

Ch'ng S, Low I, Ng D, Brasch H, Sullivan M, Davis P, Tan ST.

Hum Pathol. 2008 Mar;39(3):344-9. Epub 2007 Nov 28.

PMID:
18045646
12.

Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.

Young RJ, Lim AM, Angel C, Collins M, Deb S, Corry J, Wiesenfeld D, Kleid S, Sigston E, Lyons B, Russell PA, Wright G, McArthur GA, Fox SB, Rischin D, Solomon B.

Oral Oncol. 2013 Jun;49(6):576-81. doi: 10.1016/j.oraloncology.2013.01.006. Epub 2013 Feb 19.

PMID:
23434054
13.

Amplification of the int-2 gene in human head and neck squamous cell carcinomas.

Somers KD, Cartwright SL, Schechter GL.

Oncogene. 1990 Jun;5(6):915-20.

PMID:
2193294
14.

Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification.

Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY, El-Naggar A, Hong WK, Hittelman WN.

Oncogene. 1998 Nov 5;17(18):2313-22.

15.

Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.

Hanken H, Gaudin R, Gröbe A, Fraederich M, Eichhorn W, Smeets R, Simon R, Sauter G, Grupp K, Izbicki JR, Sehner S, Heiland M, Blessmann M.

J Oral Pathol Med. 2014 Apr;43(4):304-8. doi: 10.1111/jop.12173. Epub 2014 Mar 20.

PMID:
24645976
16.

Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.

Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.

Laryngoscope. 2002 Mar;112(3):472-81.

PMID:
12148857
17.

Prevalence, morphology, and natural history of FGFR1-amplified lung cancer, including squamous cell carcinoma, detected by FISH and SISH.

Russell PA, Yu Y, Young RJ, Conron M, Wainer Z, Alam N, Solomon B, Wright GM.

Mod Pathol. 2014 Dec;27(12):1621-31. doi: 10.1038/modpathol.2014.71. Epub 2014 Apr 25.

18.

Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.

Lee MJ, Kim N, Choung HK, Choe JY, Khwarg SI, Kim JE.

J Cancer Res Clin Oncol. 2016 Jan;142(1):125-33. doi: 10.1007/s00432-015-2009-z. Epub 2015 Jul 4.

PMID:
26141290
19.

Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer.

Kim HR, Kim DJ, Kang DR, Lee JG, Lim SM, Lee CY, Rha SY, Bae MK, Lee YJ, Kim SH, Ha SJ, Soo RA, Chung KY, Kim JH, Lee JH, Shim HS, Cho BC.

J Clin Oncol. 2013 Feb 20;31(6):731-7. doi: 10.1200/JCO.2012.43.8622. Epub 2012 Nov 26.

PMID:
23182986
20.

Copy number gain of PIK3CA and MET is associated with poor prognosis in head and neck squamous cell carcinoma.

Brauswetter D, Dános K, Gurbi B, Félegyházi ÉF, Birtalan E, Meggyesházi N, Krenács T, Tamás L, Peták I.

Virchows Arch. 2016 May;468(5):579-87. doi: 10.1007/s00428-016-1905-1. Epub 2016 Jan 29.

PMID:
26832731

Supplemental Content

Support Center